Insider Cluster (4 insiders) ·Filed Jul 20, 2026

INCY

INCYTE CORP
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $341K total
Actionable Insight • Neutral

The insider sales are trivial in size and likely routine portfolio diversification. The stock grants are non-cash compensation. No actionable signal — monitor next quarterly earnings for any fundamental changes.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
INCY ▲ +6.79% at T+20d
NEUTRAL call ✓ call won +6.79% · α vs SPY +2.67% · entry $115.65 → $123.50
Next anchor: T+60d in 10d
Latest observation: T+51 -4.79% FF3 residual α
Entry anchored
Jul 17, 03:59 PM ET
via exchange tick
T+1d
+1.50%
call +1.50% · α +0.67%
$117.39
settled 2mo ago
T+5d
+1.75%
call +1.75% · α +2.17%
$117.67
settled 2mo ago
T+20d
+6.79%
call +6.79% · α +2.67%
$123.50
settled 7w ago
T+60d
—
call — · α —
—
in 10d

Price Chart

Loading chart...

Executive Summary

Two senior INCY executives (CMO and EVP of U.S. Commercial) sold a combined $341K of stock on July 16, 2026, while two other EVPs received non-cash stock grants on July 23. The sales are modest at ~0.001% of market cap, and the grants are routine compensation events. The cluster is mixed (sales + grants) with no material directional signal.

Key Financial Metrics

Direction
mixed
Total Value
$341.0K
Insiders
4

Key Facts

  • CMO Steven H. Stein sold 1,900 shares for $215K on July 16
  • EVP Issa Mohamed Khairie sold 1,100 shares for $126K on July 16
  • Two EVPs received non-cash stock grants totaling 44,346 shares on July 23
  • Total open-market sales of $341K represent ~0.001% of INCY's $23.5B market cap
  • No insider open-market purchases in the cluster

Financial Impact

Total insider sales of $341K, negligible relative to $23.5B market cap

insider ownership

Risk Factors

  • Insider sales, though small, could precede a negative catalyst if they accelerate
  • No insider buying to offset the sales leaves a mildly cautious tone

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
52% bullish (33 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INCY-1785193265146
9 reports for INCY
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+60▲ +23.70%Jun 8, 2026
Filters
Rows
Reports for INCY — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$120.16 $122.19▼ −1.69%▼ −3.68%$115.30 (+4.04%)
Aug 7, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$121.55 $124.40▲ +2.34%▲ +3.26%$115.30 (−5.14%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$120.60 $124.50▲ +3.23%▲ +4.47%$115.30 (−4.39%)
Jul 28, 2026
9w ago
8-K
MIXED ★ 6/10
$129.93 $129.72▼ −0.16%▼ −3.54%$115.30 (−11.26%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$115.65 $123.50▲ +6.79%▲ +2.67%$115.30 (−0.30%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$115.65 $123.50▲ +6.79%▲ +2.67%$115.30 (−0.30%)
Jun 8, 2026
16w ago
8-K
BULLISH ★ 7/10
$100.64 $115.62▲ +14.88%▲ +13.25%$115.30 (+14.57%)
May 27, 2026
18w ago
DEFA14A
NEUTRAL ★ 3/10
$97.26 $108.46▲ +11.52%▲ +13.82%$115.30 (+18.55%)
Feb 28, 2026
30w ago
Institutional Cluster
BULLISH ★ 6/10
$99.73 $90.31▼ −9.45%▼ −1.51%$115.30 (+15.62%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 27, 2026